LQDA.NASDAQLiquidia CORP

Form 4: Liquidia Corp's Chief Medical Officer Sells Shares to Cover Taxes

Sentiment:

SEC Form 4 Filing


Rajeev Saggar, Chief Medical Officer of Liquidia Corp, sold 1,873 shares of common stock to cover taxes associated with the settlement of restricted stock units.

Summary

  • Rajeev Saggar, the Chief Medical Officer of Liquidia Corp, filed a Form 4 indicating changes in beneficial ownership.
  • On July 19, 2024, Saggar sold 1,873 shares of Liquidia Corp common stock at a price of $11.13 per share.
  • The sale was executed to cover taxes associated with the settlement of restricted stock units (RSUs) granted on July 18, 2022.
  • Following the transaction, Saggar beneficially owns 208,329 shares of Liquidia Corp, which includes unvested RSUs from grants in 2022, 2023 and 2024, as well as shares acquired through the Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions by an insider. The sale of shares to cover taxes is a neutral event and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it involves a small number of shares sold by an executive.

Key Dates

DateDescription
December 15, 2023Date the Reporting Person adopted a Rule 10b5-1 plan
July 18, 2022Date of initial RSU grant related to the tax obligation.
January 11, 2023Date of RSU grant.
January 11, 2024Date of RSU grant.
July 19, 2024Date of the stock sale transaction.
July 22, 2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.